These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 39161067)
1. Using natriuretic peptides to screen for, identify and treat stage B heart failure in people with type 2 diabetes: An initial cost-effectiveness analysis. Horton WB; Dart ME; Kavuru VS; Girton MR; Jin R Diabetes Obes Metab; 2024 Nov; 26(11):5470-5473. PubMed ID: 39161067 [No Abstract] [Full Text] [Related]
2. [A national campaign for the promotion of the appropriate use of natriuretic peptide assays in heart failure patients]. Di Lenarda A G Ital Cardiol (Rome); 2016 Jan; 17(1):48-50. PubMed ID: 26901258 [No Abstract] [Full Text] [Related]
3. The cost effectiveness of B-Type natriuretic peptide measurement in the primary care setting-a UK perspective. Collinson PO Congest Heart Fail; 2006; 12(2):103-7. PubMed ID: 16596045 [No Abstract] [Full Text] [Related]
5. Cost effectiveness of natriuretic peptide measurement in the primary care setting: have we found the gatekeeper for the evaluation of dyspneic outpatients? Baggish AL; Januzzi JL Congest Heart Fail; 2006; 12(2):108-9. PubMed ID: 16596046 [No Abstract] [Full Text] [Related]
6. Emerging Biomarkers in the Laboratory and in Practice: A Novel Approach to Diagnosing Heart Failure in Diabetes. Aaron RE; Tian T; Fleming GA; Sacks DB; Januzzi JL; Facc MD; Pop-Busui R; Hashim IA; Wu AHB; Pandey A; Klonoff DC J Diabetes Sci Technol; 2024 May; 18(3):733-740. PubMed ID: 38292004 [TBL] [Abstract][Full Text] [Related]
7. Influence of diabetes on natriuretic peptide thresholds in screening for Stage B heart failure. Watson C; James S; O'Connell E; Gallagher J; O'Reilly J; Tallon E; Baugh J; O'Connell J; O'Shea D; Ledwidge M; McDonald K Biomarkers; 2016 Sep; 21(6):538-43. PubMed ID: 27049231 [TBL] [Abstract][Full Text] [Related]
8. B-type natriuretic peptide: time to incorporate natriuretic peptides in our practice. Daniels LB; Maisel A J Cardiovasc Med (Hagerstown); 2006 Jun; 7(6):414-5. PubMed ID: 16721203 [No Abstract] [Full Text] [Related]
9. Diagnostic accuracy of natriuretic peptides for acute heart failure: a review. Zhou SL; Zhang J; Song TT; Li X; Wang HX Eur Rev Med Pharmacol Sci; 2018 Apr; 22(8):2415-2420. PubMed ID: 29762843 [TBL] [Abstract][Full Text] [Related]
10. Natriuretic Peptides and Heart Stress: Time to Screen the Asymptomatic High-Risk Population to Prevent Incident Heart Failure? Villacorta H; Souza DG; Jorge AJL Arq Bras Cardiol; 2024 Aug; 121(8):e20230910. PubMed ID: 39194044 [No Abstract] [Full Text] [Related]
12. Natriuretic peptide and cardiovascular risk: is it about "U"? deFilippi CR; Seliger SL J Am Heart Assoc; 2015 May; 4(5):. PubMed ID: 25999399 [No Abstract] [Full Text] [Related]
13. Increases in Natriuretic Peptides Precede Heart Failure Hospitalization in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus. Wolsk E; Claggett B; Diaz R; Dickstein K; Gerstein HC; Køber L; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Pfeffer MA Circulation; 2017 Oct; 136(16):1560-1562. PubMed ID: 29038210 [No Abstract] [Full Text] [Related]
14. Cost-effectiveness of screening strategies to detect heart failure in patients with type 2 diabetes. van Giessen A; Boonman-de Winter LJ; Rutten FH; Cramer MJ; Landman MJ; Liem AH; Hoes AW; Koffijberg H Cardiovasc Diabetol; 2016 Mar; 15():48. PubMed ID: 27001409 [TBL] [Abstract][Full Text] [Related]
15. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus. Wolsk E; Claggett B; Pfeffer MA; Diaz R; Dickstein K; Gerstein HC; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Køber L J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28554908 [TBL] [Abstract][Full Text] [Related]
16. Hypervolemic and optivolemic natriuretic peptides in acute heart failure. Xue Y; Taub PR; Fard A; Maisel AS Contrib Nephrol; 2011; 171():74-79. PubMed ID: 21625093 [TBL] [Abstract][Full Text] [Related]
17. Is it NICE to measure natriuretic peptides after a hospitalization for heart failure? Pagnesi M; Adamo M; Metra M Eur J Heart Fail; 2024 Apr; 26(4):785-787. PubMed ID: 38654473 [No Abstract] [Full Text] [Related]
18. Natriuretic peptides revisited: new potentials and challenges in heart failure. Farmakis D; Parissis J; Papingiotis G; Lekakis J; Filippatos G J Cardiovasc Med (Hagerstown); 2016 Nov; 17(11):840-2. PubMed ID: 27680306 [No Abstract] [Full Text] [Related]
19. Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: new challenges and perspectives. Clerico A; Passino C; Franzini M; Emdin M Future Cardiol; 2016 Sep; 12(5):573-84. PubMed ID: 27459871 [TBL] [Abstract][Full Text] [Related]
20. Relationship between natriuretic peptides and echocardiography parameters in patients with poorly regulated type 2 diabetes. Dencker M; Stagmo M; Dorkhan M Vasc Health Risk Manag; 2010 Jun; 6():373-82. PubMed ID: 20539839 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]